Imaging and clinical characteristics reach high diagnostic efficacy when they are used to identify frequent acute exacerbations in patients with chronic obstructive pulmonary disease (COPD).
A mix of imaging and clinical characteristics was able to identify the frequent acute exacerbations phenotype in patients with chronic obstructive pulmonary disease (COPD), according to a new study.
COPD is a common disease with high morbidity, with acute exacerbations resulting in worsening of respiratory symptoms. This study, which aimed to identify frequent acute exacerbations in patients with COPD using imaging and clinical characteristics, found that patients with frequent exacerbations had a larger low attenuation area less than –950 Hu (LAA-950), and tended to have more severe visual subtypes, suggesting new treatment guidance for patients who have already received a COPD diagnosis.
“Multivariate binary logistic regression indicated that clinical indicators combined with imaging characteristics played an important role in predicting frequent exacerbations of patients who were initially diagnosed with COPD,” wrote the researchers of this study. “Increases in LAA-950 and worsening of visual subtypes symbolized more frequent exacerbations.”
The results of this retrospective study were published in Respiratory Medicine.
This study initially recruited 261 patients whose COPD was diagnosed using pulmonary function tests (PFTs) from January 2020 to May 2022 in Shanghai, China. Patient data included age, sex, symptoms upon admission, smoking status, height, weight, and PFT indicators. Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) were measured by severity: mild, moderate, and severe.
Patients with comorbid lung cancer, who had received lung surgery, who had bronchiectasis, and who were missing information were excluded, leaving 201 patients in this study. Of these patients, 112 were placed into a nonfrequent exacerbation group and 89 patients were placed in a frequent exacerbation group. For this analysis, frequent AECOPD was split into 2 definitions:
All patients received an inspiratory high-resolution CT examination and PFTs, which evaluated forced expiratory volume at 1 second (FEV1); forced vital capacity (FVC); FEV1/FVC; percentage of FEV1, the predicated value (FEV1 pred); residual volume; and total lung volume.
The researchers followed patients for up to 1 year after their initial diagnosis and divided them into the frequent and nonfrequent exacerbation groups.
Patients with frequent exacerbations had a greater risk of larger LAA-950 than those with nonfrequent exacerbations (odds ratio [OR], 1.322; 95% CI, 1.19-1.47; P < .001). Frequent COPD exacerbations were associated with worsening visual subtypes, age, smoking status, body mass index, FEV1 pred, and LAA-950.
Age older than 65 years, being a former or current smoker, and having a BMI ≤ 23.39, an FEV1 pred ≤ 50.10, and LAA-950 > 20.30 were associated with frequent acute exacerbations.
Lastly, sensitivity, specificity, and area under the receiver operating characteristic curve (AUC-ROC) were used to predict frequent acute exacerbations and total prediction probability. The researchers found that the frequent acute exacerbation group had the highest AUC-ROC, of 0.907 (Z = 19.76; 95% CI, 0.86-0.94; P < .001), while the prediction probability in the nonfrequent acute exacerbation group was an AUC of 0.895 (Z = 17.92; 95% CI, 0.84-0.92; P < .001).
The researchers acknowledged that this study has some limitations, including that patients with mild exacerbations may be heterogeneous in their symptoms and tolerance. Additionally, some symptoms may have been extensions of COPD, making distinguishing between symptoms difficult.
However, despite these limitations, the researchers were able to demonstrate a strong association between risk factors of frequent acute exacerbations in patients with COPD by using imaging and clinical characteristics.
“In conclusion, we found that, in patients with frequent exacerbations of COPD, the LAA-950 was larger, and the visual subtypes tended to the more severe phenotype,” wrote the researchers. “Combining imaging and basic clinical characteristics reached good diagnostic efficacy in predicting frequent acute exacerbations of COPD. This may provide a new treatment direction for patients who are initially diagnosed with COPD.”
Reference
Zhu D, Dai H, Zhu H, et al. Identification of frequent acute exacerbations phenotype in COPD patients based on imaging and clinical characteristics. Respiratory Medicine. Published online February 8, 2023. doi:10.1016/j.rmed.2023.107150
Higher Life’s Essential 8 Scores Associated With Reduced COPD Risk
November 21st 2024Higher Life’s Essential 8 (LE8) scores, especially those reflecting lower nicotine exposure and better sleep health, are inversely associated with chronic obstructive pulmonary disease (COPD) risk, emphasizing the importance of cardiovascular health (CVH) in disease prevention.
Read More
A Pulmonologist on Why You Should Think About Respiratory Health and the Lungs
November 16th 2021On this episode of Managed Care Cast, we speak with MeiLan K. Han, MD, MS, the author of a book released this month called Breathing Lessons: A Doctor’s Guide to Lung Health. Han, a pulmonologist, gives an inside tour of the lungs and how they work, zooms out to examine the drivers of poor respiratory health, and addresses policy changes that are needed to improve lung health.
Listen
Interstitial Lung Abnormalities in Patients With COPD Linked to Cancer, Heart Failure Risks
October 23rd 2024Interstitial lung abnormalities (ILAs) in patients with chronic obstructive pulmonary disease (COPD) are linked to lower lung adenocarcinoma rates but higher rates of other cancers and heart failure.
Read More
Ineligibility, Limitations to PR Uptake in Patients With AECOPD
October 15th 2024Two posters at the CHEST 2024 annual meeting revealed that 18% of eligible patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) participated in post-discharge pulmonary rehabilitation (PR), with ineligibility significantly limiting uptake.
Read More